Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 347

1.

Mechanisms of hypervirulent Clostridium difficile ribotype 027 displacement of endemic strains: an epidemiological model.

Yakob L, Riley TV, Paterson DL, Marquess J, Magalhaes RJ, Furuya-Kanamori L, Clements AC.

Sci Rep. 2015 Jul 28;5:12666. doi: 10.1038/srep12666.

PMID:
26218654
2.

A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis.

Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C, Shirwadkar C, Eastwood GM, Myburgh J, Paterson DL, Starr T, Paul SK, Lipman J.

Am J Respir Crit Care Med. 2015 Jul 22. [Epub ahead of print]

PMID:
26200166
3.

Community-Acquired Pyelonephritis in Pregnancy Caused by KPC-Producing Klebsiella pneumoniae.

Khatri A, Naeger Murphy N, Wiest P, Osborn M, Garber K, Hecker M, Hurless K, Rudin SD, Jacobs MR, Kalayjian RC, Salata RA, van Duin D, Perez F, Bonomo RA, Paterson DL, Harris PN.

Antimicrob Agents Chemother. 2015 Aug;59(8):4375-8. doi: 10.1128/AAC.00553-15.

PMID:
26185273
4.

The Use of Therapeutic Drug Monitoring to Optimize Treatment of Carbapenem-Resistant Enterobacter Osteomyelitis.

Stewart A, Graves B, Hajkowicz K, Ta K, Paterson DL.

Microb Drug Resist. 2015 Jul 14. [Epub ahead of print]

PMID:
26171974
5.

Assessing control bundles for Clostridium difficile: a review and mathematical model.

Yakob L, Riley TV, Paterson DL, Marquess J, Clements AC.

Emerg Microbes Infect. 2014 Jun;3(6):e43. doi: 10.1038/emi.2014.43. Epub 2014 Jun 18.

6.

Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two 'old' antibiotics-polymyxin B and chloramphenicol.

Abdul Rahim N, Cheah SE, Johnson MD, Yu H, Sidjabat HE, Boyce J, Butler MS, Cooper MA, Fu J, Paterson DL, Nation RL, Bergen PJ, Velkov T, Li J.

J Antimicrob Chemother. 2015 May 28. pii: dkv135. [Epub ahead of print]

PMID:
26023209
7.

Antimicrobial susceptibility reporting and treatment selection for AmpC-producing Enterobacteriaceae: what do microbiologists and infectious disease practitioners actually practice?

Harris PN, Alder L, Paterson DL.

Pathology. 2015 Jun;47(4):386-8. doi: 10.1097/PAT.0000000000000255. No abstract available.

PMID:
25938360
8.

Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae.

Harris PN, Yin M, Jureen R, Chew J, Ali J, Paynter S, Paterson DL, Tambyah PA.

Antimicrob Resist Infect Control. 2015 May 1;4:14. doi: 10.1186/s13756-015-0055-6. eCollection 2015.

9.

Dominance of IMP-4-Producing Enterobacter cloacae among Carbapenemase-Producing Enterobacteriaceae in Australia.

Sidjabat HE, Townell N, Nimmo GR, George NM, Robson J, Vohra R, Davis L, Heney C, Paterson DL.

Antimicrob Agents Chemother. 2015 Jul;59(7):4059-66. doi: 10.1128/AAC.04378-14. Epub 2015 Apr 27.

PMID:
25918153
10.

Reply to Bonten and Mevius.

Lazarus B, Paterson DL, Mollinger JL, Rogers BA.

Clin Infect Dis. 2015 Jun 15;60(12):1867-8. doi: 10.1093/cid/civ276. Epub 2015 Apr 24. No abstract available.

PMID:
25911644
11.

PME-1-producing Pseudomonas aeruginosa in Qatar.

Zowawi HM, Ibrahim E, Syrmis MW, Wailan AM, AbdulWahab A, Paterson DL.

Antimicrob Agents Chemother. 2015 Jun;59(6):3692-3. doi: 10.1128/AAC.00424-15. Epub 2015 Apr 13. No abstract available.

PMID:
25870054
12.

Draft Genome Sequence of NDM-5-Producing Escherichia coli Sequence Type 648 and Genetic Context of blaNDM-5 in Australia.

Wailan AM, Paterson DL, Caffery M, Sowden D, Sidjabat HE.

Genome Announc. 2015 Apr 9;3(2). pii: e00194-15. doi: 10.1128/genomeA.00194-15.

13.

Editorial Commentary: The New Acinetobacter Equation: Hypervirulence Plus Antibiotic Resistance Equals Big Trouble.

Paterson DL, Harris PN.

Clin Infect Dis. 2015 Jul 15;61(2):155-6. doi: 10.1093/cid/civ227. Epub 2015 Mar 29. No abstract available.

PMID:
25824816
14.

Synthesis of the furo[2,3-b]chromene ring system of hyperaspindols A and B.

Paterson DL, Barker D.

Beilstein J Org Chem. 2015 Feb 17;11:265-70. doi: 10.3762/bjoc.11.29. eCollection 2015.

15.

Multidrug-resistant Escherichia coli in Asia: epidemiology and management.

Sidjabat HE, Paterson DL.

Expert Rev Anti Infect Ther. 2015 May;13(5):575-91. doi: 10.1586/14787210.2015.1028365. Epub 2015 Mar 24.

PMID:
25805210
16.

Clostridium difficile infection seasonality: patterns across hemispheres and continents - a systematic review.

Furuya-Kanamori L, McKenzie SJ, Yakob L, Clark J, Paterson DL, Riley TV, Clements AC.

PLoS One. 2015 Mar 16;10(3):e0120730. doi: 10.1371/journal.pone.0120730. eCollection 2015.

17.

Local acquisition and nosocomial transmission of Klebsiella pneumoniae harbouring the blaNDM-1 gene in Australia.

Tai AY, Stuart RL, Sidjabat HE, Lemoh CN, Rogers BA, Graham M, Paterson DL, Korman TM.

Med J Aust. 2015 Mar 16;202(5):270-2. No abstract available.

PMID:
25758700
18.

β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options?

Harris PN, Tambyah PA, Paterson DL.

Lancet Infect Dis. 2015 Apr;15(4):475-85. doi: 10.1016/S1473-3099(14)70950-8. Epub 2015 Feb 23. Review.

PMID:
25716293
19.

Molecular Epidemiology and Mechanisms of Carbapenem Resistance of Acinetobacter spp. in Asia and Oceania.

Kamolvit W, Sidjabat HE, Paterson DL.

Microb Drug Resist. 2015 Aug;21(4):424-34. doi: 10.1089/mdr.2014.0234. Epub 2015 Feb 25.

PMID:
25714653
20.

Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New Zealand.

Rogers BA, Ingram PR, Runnegar N, Pitman MC, Freeman JT, Athan E, Havers S, Sidjabat HE, Gunning E, De Almeida M, Styles K, Paterson DL; ASID CRN.

Int J Antimicrob Agents. 2015 Apr;45(4):351-8. doi: 10.1016/j.ijantimicag.2014.11.015. Epub 2015 Jan 13.

PMID:
25707371
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk